Association between statin usage and prostate cancer prevention: A refined meta-analysis based on literature from the years 2005-2010

Urologia Internationalis

Volumn 90, Issue 3, 2013, Pages 259-262

  Zhang, Yong ^a   Zang, Tong ^a  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

Meta analysis; Prostate cancer; Statins

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CANCER INCIDENCE; CANCER PREVENTION; CANCER THERAPY; CLINICAL ASSESSMENT; CLINICAL EVALUATION; DISEASE ASSOCIATION; DRUG USE; EPIDEMIOLOGICAL DATA; HUMAN; META ANALYSIS; MOLECULAR RECOGNITION; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW;

EID: 84876826457     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000341977     Document Type: Review

References (17)

1. Murtola TJ, Visakorpi T, Lahtela J, Syvala H, Tammela TLJ: Statins and prostate cancer prevention: where we are now, and future directions. Nat Clin Pract Urol 2007; 5: 376-387.
2. Bonovas S, Filioussi K, Sitaras NM: Statin use and the risk of prostate cancer: A metaanalysis of 6 randomized clinical trials and
3. observational studies. Int J Cancer 2008; 123: 899-904.
4. Karp I, Behlouli H, Lelorier J, Pilote L: Statins and cancer risk. Am J Med 2008; 121: 302-309.
5. Cauley JA, McTiernan A, Rodabough RJ, La-Croix A, Bauer DC, Margolis KL, Paskett ED, Vitolins MZ, Furberg CD, Chlebowski RT, Women's Health Initiative Research Group: Statin use and breast cancer: prospective results from the Women's Health Initiative. J Natl Cancer Inst 2006; 98: 700-708.
6. Shannon J, Tewoderos S, Garzotto M, et al: Statins and prostate cancer risk: A case-control study. Am J Epidemiol 2005; 162: 318-325.
7. Browning DR, Martin RM: Statins and risk of cancer: A systematic review and metaanalysis. Int J Cancer 2007; 120: 833-843.
8. Bonovas S, Filioussi K, Tsavaris N, Sitaaras NM: Statins and cancer risk: A literaturebased meta-analysis and meta-regression analysis of 35 randomized controlled trials. J Clin Oncol 2006; 24: 4808-4817.
9. Hamilton RJ, Freedland SJ: Review of recent evidence in support of a role for statins in the prevention of prostate cancer. Curr Opin Urol 2008; 18: 333-339.
10. Platz EA, Leitzmann MF, Visvanathan K, Rimm EB, Stampfer MJ, Willett WC, Giovannucci E: Statin drugs and risk of advanced prostate cancer. J Natl Cancer Inst 2006; 98: 1819-1825.
11. Agalliu I, Salinas CA, Hansten PD, Ostrander EA, Stanford JL: Statin use and risk of prostate cancer: results from a populationbased epidemiologic study. Am J Epidemiol 2008; 168: 250-260.
12. Haukka J, Sankila R, Klaukka T, Lonnqvist J, Niskanen L, Tanskanen A, Wahlbeck K, Tiihonen J: Incidence of cancer and statin usage-record linkage study. Int J Cancer 2010; 126: 279-284.
13. Taylor ML, Wells BJ, Smolak MJ: Statins and cancer: A meta-analysis of case-control studies. Eur J Cancer Prev 2008; 17: 259-268.
14. Colli JL, Amling CL: High cholesterol levels are associated with reduced prostate cancer mortality rates during periods of high but not low statin use in the United States. Urol Oncol 2009; 27: 170-173.
15. Flick ED, Habel LA, Chan KA, et al: Statin use and risk of prostate cancer in the California Men's Health Study cohort. Cancer Epidemiol Biomarkers Prev 2007;16:2218-2225.
16. Boudreau DM, Yu O, Buist DS, Miglioretti DL: Statin use and prostate cancer risk in a large population-based setting. Cancer Causes Control 2008;19:767-774.
17. Murtola TJ: Statin use is associated with improved prostate cancer survival: is it time for a clinical trial? Expert Rev Anticancer Ther 2010;10:1563-1567.